These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 27623620)

  • 1. Repeated iodine-125 seed implantations combined with external beam radiotherapy for the treatment of locally recurrent or metastatic stage III/IV non-small cell lung cancer: a retrospective study.
    Li W; Dan G; Jiang J; Zheng Y; Zheng X; Deng D
    Radiat Oncol; 2016 Sep; 11(1):119. PubMed ID: 27623620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy and safety of chemotherapy combined with interstitial (125)I seed implantation brachytherapy in unresectable stage IIIa/IIIb non-small cell lung cancer].
    Yang SF; Fan XW; Zhang GQ; Shan L
    Zhonghua Zhong Liu Za Zhi; 2010 Aug; 32(8):626-9. PubMed ID: 21122419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gemcitabine, cisplatin, and hyperfractionated accelerated radiotherapy for locally advanced non-small cell lung cancer.
    Zwitter M; Kovac V; Smrdel U; Strojan P
    J Thorac Oncol; 2006 Sep; 1(7):662-6. PubMed ID: 17409933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrating concurrent navelbine and cisplatin to hyperfractionated radiotherapy in locally advanced non-small cell lung cancer patients treated with induction and consolidation chemotherapy: feasibility and activity results.
    Reguart N; Viñolas N; Casas F; Gimferrer JM; Agustí C; Molina R; Martin-Richard M; Sanchez-Reyes A; Gascón P
    Lung Cancer; 2004 Jul; 45(1):67-75. PubMed ID: 15196736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The combined treatment of CT-guided percutaneous 125I seed implantation and chemotherapy for non-small-cell lung cancer.
    Zhang S; Zheng Y; Yu P; Yu F; Zhang Q; Lv Y; Xie X; Gao Y
    J Cancer Res Clin Oncol; 2011 Dec; 137(12):1813-22. PubMed ID: 21922327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Final overall results of a study with a novel triplet induction chemotherapy regimen (PACCAGE) followed by consolidation radiotherapy in locally advanced inoperable non-small cell lung cancer (NSCLC).
    Schallier D; Bral S; Ilsen B; Neyns B; Fontaine C; Decoster L; De Mey J; Meysman M; De Grève J
    J Thorac Oncol; 2009 Jun; 4(6):728-35. PubMed ID: 19404217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Induction chemotherapy followed by concomitant combined radiotherapy and chemotherapy in stage III non-small cell bronchial carcinoma].
    Bouillet T; Morère JF; Mazeron JJ; Piperno-Neuman S; Boaziz C; Haddad E; Breau JL
    Cancer Radiother; 1997; 1(2):121-31. PubMed ID: 9273182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung function changes and pulmonary complications in patients with stage III non-small cell lung cancer treated with gemcitabine/cisplatin as part of combined modality treatment.
    Maas KW; van der Lee I; Bolt K; Zanen P; Lammers JW; Schramel FM
    Lung Cancer; 2003 Sep; 41(3):345-51. PubMed ID: 12928125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II study of induction chemotherapy with gemcitabine and vinorelbine followed by concurrent chemoradiotherapy with oral etoposide and cisplatin in patients with inoperable stage III non-small-cell lung cancer.
    Lee DH; Han JY; Cho KH; Pyo HR; Kim HY; Yoon SJ; Lee JS
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1037-44. PubMed ID: 16024178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of a phase II concurrent chemoradiotherapy study using three-dimensional conformal radiotherapy with cisplatin and oral etoposide in stage III nonsmall-cell lung cancer.
    Chen LM; Ignacio L; Jacobs R; Kozloff M; Telfer M; Elahi R; Evans R; Vijayakumar S
    Radiat Oncol Investig; 1999; 7(1):49-53. PubMed ID: 10030624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computed Tomography-Guided Interstitial High-Dose-Rate Brachytherapy in Combination With Regional Positive Lymph Node Intensity-Modulated Radiation Therapy in Locally Advanced Peripheral Non-Small Cell Lung Cancer: A Phase 1 Clinical Trial.
    Xiang L; Zhang JW; Lin S; Luo HQ; Wen QL; He LJ; Shang CL; Ren PR; Yang HR; Pang HW; Yang B; He HL; Chen Y; Wu JB
    Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1027-1034. PubMed ID: 26194678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant chemotherapy in locally advanced non-small cell lung cancer.
    Hamouda W; Dorgham Y; Yosry A; Abdel Wahab M
    Gulf J Oncolog; 2007 Jul; (2):55-64. PubMed ID: 20084725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High frequency of radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent radiotherapy and gemcitabine after induction with gemcitabine and carboplatin.
    Arrieta O; Gallardo-Rincón D; Villarreal-Garza C; Michel RM; Astorga-Ramos AM; Martínez-Barrera L; de la Garza J
    J Thorac Oncol; 2009 Jul; 4(7):845-52. PubMed ID: 19487963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel triplet regimen with paclitaxel, carboplatin and gemcitabine (PACCAGE) as induction chemotherapy for locally advanced unresectable non small cell lung cancer (NSCLC).
    Schallier D; Neyns B; Fontaine C; Steene JV; De Mey J; Meysman M; De Grève J
    Lung Cancer; 2007 May; 56(2):247-54. PubMed ID: 17337086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II multicenter trial with carboplatin and gemcitabine induction chemotherapy followed by radiotherapy concomitantly with low-dose paclitaxel and gemcitabine for stage IIIA and IIIB non-small cell lung cancer.
    Hirsh V; Soulieres D; Duclos M; Faria S; Del Vecchio P; Ofiara L; Ayoub JP; Charpentier D; Gruber J; Portelance L; Souhami L
    J Thorac Oncol; 2007 Oct; 2(10):927-32. PubMed ID: 17909355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gemcitabine-cisplatin given on day 1 every 3 weeks in advanced non-small cell lung cancer.
    Karacetin D; Incekara O
    J BUON; 2006; 11(2):181-4. PubMed ID: 17318968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consolidative Radiotherapy for Limited Metastatic Non-Small-Cell Lung Cancer: A Phase 2 Randomized Clinical Trial.
    Iyengar P; Wardak Z; Gerber DE; Tumati V; Ahn C; Hughes RS; Dowell JE; Cheedella N; Nedzi L; Westover KD; Pulipparacharuvil S; Choy H; Timmerman RD
    JAMA Oncol; 2018 Jan; 4(1):e173501. PubMed ID: 28973074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent cisplatin, etoposide, and radiotherapy for unresectable stage III nonsmall cell lung cancer: a phase II study.
    Reboul F; Brewer Y; Vincent P; Chauvet B; Faure CF; Taulelle M
    Int J Radiat Oncol Biol Phys; 1996 May; 35(2):343-50. PubMed ID: 8635942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iodine-125 brachytherapy improved overall survival of patients with inoperable stage III/IV non-small cell lung cancer versus the conventional radiotherapy.
    Li W; Guan J; Yang L; Zheng X; Yu Y; Jiang J
    Med Oncol; 2015 Jan; 32(1):395. PubMed ID: 25428394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gemcitabine and cisplatin as induction regimen for patients with biopsy-proven stage IIIA N2 non-small-cell lung cancer: a phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group (EORTC 08955).
    Van Zandwijk N; Smit EF; Kramer GW; Schramel F; Gans S; Festen J; Termeer A; Schlosser NJ; Debruyne C; Curran D; Giaccone G
    J Clin Oncol; 2000 Jul; 18(14):2658-64. PubMed ID: 10894864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.